The webapp d-diabetes.com, an initiative of the Lilly Pharmaceutical Company to respond to the demand for diabetes information by the Primary Care Professionand family and community medicine (SEMFYC).
Since its launch, in October 2015, the web has constantly expanded its contents and currently resolves a total of 92 basic and frequent questions about the management of the disease, ”reports the driving laboratory of said platform.
"Both the website and the app are designed as an eminently practice, For his part, the medical director of Lilly Diabetes and coordinator of this tool, Dr. Jesús Reviriego.
Collected by a Committee of Specialists in Diabetes and Primary Care, the questions of the platform are grouped into 11 thematic blocks: screening, diagnosis and risk factors;Recommendations and control objectives;complications in diabetes;diet and exercise;treatment;hypoglycemia;woman and diabetes;children and adolescents;trips;special situations;and referrals to the specialist.
Good reception of professionals
Since its launch, the website has registered more than 65,000 pages visualizations and 11,700 unique visits, with an average permanence time per nine -minute visit.So far, the most frequent consultation issues have been those related to treatment;Recommendations and control objectives;diet and exercise;screening, diagnosis and risk factors.
“Primary care doctors need every day to solve doubts that do not always find a quick and simple response in their usual sources of consultation, and this tool is of great help.The endorsement of Semergen and SemfyC is another sample of the good reception that has had among these health professionals, ”says Jesús Reviriego.
